focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Deerhunter,
I'm keeping an eye on it. Thought they would have announced some sort of corporate action for funding strategy to get FDA done by now, but apparently, it's any time until the end of March when this could be unveiled. That's where it could get interesting quite quickly, USA. So if something moves on that side of things, I might reinvest again.
I make current cash position either £900k if they've not received the tax credit, or £1.7m if they've already had it.
GDR didn't even know exactly when Gloria. They may have received it by now anyway. It's not an RNSable event.
Agreed Blubay,
My guess is already forward sold.
I think this is why Burford wanted the case to be heard in Texas. But the other side managed to get it moved.
To me whether Burford share price makes big progress from current point, is mainly about YPF anyway. For that reason, I recently decided to sell out of quite a large position in Burford as the buzz on that side of things seemed to have died down. Will watch and may re-enter if I see cheep entry point. I know I risk losing big gains if something is suddenly announced RE Argentina out of the blue. We'll see.
Mozax,
I had more than a stiff foot about a month ago. I ended up at A&E walk in cause it had swelled to nearly twice it's normal size due to infection! (so now I'm trying to keep my feet in better condition, so that doesn't happen again.)
Lol, I was Bucolic. You should go into Boots and have a look. If it's the same set up as mine, it's all kept behind the counter near where the pharmacist is. I'm guessing that's because there's an age restriction??
Just saw the product in my local Boots. In very prominent position behind medicines counter next to Viagra. (I was in there to get foot cream, then I realised I was in the wrong part of the store.)
I just picked up another £10k at 38p. The ask price was 44p this morning, but I wasn't going to pay that much today!
"the Group remains on track to reach cash flow break even as planned, with the Company well positioned to meet its stated growth ambitions."
Thought this might rise today given the bit about breaking even. Anyone?
If it's 0.3p by August, these share options at 6p will look like a proper incentive to do well. lol
Thanks for tip
Looks to me like 43p is key resistance to scale....
Lloydf,
"these will go back down to 25p in the short term"
Any other reason you think this, other than it being an AIM share lol?
Manolo,
I just invested £20k today for first time. Looks like a decent punt. When do you think they'll enter profitability?
I don't see anything positive happening here for shareholders for a while now. I just put £20k into Futura Medical. They did trading update today. I thought worth a punt.
My understanding is GDR only hoping to get greenlight to rollout stroke marker in Manchester area at the moment anyway. The write-up from NICE will say more testing needs to be done etc. My guess is latest delay is due to scheduling issues and manpower of people on committee etc. GDR made it clear the big short term hope was getting funding to progress FDA. To me this is the important outstanding piece of news at the moment. But I thought we would of heard something by now on this front.....
Found it interesting to listen to the presentation again, the outlook statements on youtube, with the script on (essentially youtube subtitles.) He doesn't contradict anything in the results RNS, but he does put a bit of a gloss on things, as you would expect for what is essentially a salesy presentation. The bit where he says he's 100% sure specialist commissioning will happen is slightly amusing. As within seconds he qualifies by saying he'll be speaking to loads of people to make it happen etc. Because obviously it's not his decision whether NHS England decides to to go for specialist commissioning or not and they haven't even held public consultation yet.
Relistening to presentation JLC, both figures are actually correct on cash burn, shown on slide 15. Cash burn is £400k per month, but if the R&D tax credit is deducted from that, it falls to £327k. So actual cash burn is £400k per month, but adjusted cash burn is £327k per month. In other words, its £400k until the point when they receive the tax credit, and then it's not if you factor that in. lol
But they do need really big year-on-year percentage sales growth just to breakeven....